SEARCH

SEARCH BY CITATION

References

  • 1
    Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics – 2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2009; 119:480486.
  • 2
    Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 2005; 149:209216.
  • 3
    Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry (ADHERE) database. J Am Coll Cardiol 2006; 47:7684.
  • 4
    Cleland JGF, Swedberg K, Follath F, et al. The euroheart failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24:442463.
  • 5
    Komajda M, Folath F, Swedberg K, et al. The euroheart failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003; 24:464474.
  • 6
    Nieminen MS, Brutsaert D, Dickstein K, et al. Euro heart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27:27252736.
  • 7
    Rohde LE, Goldraich L, Polanczyk CA, et al. A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail 2006; 12:587593.
  • 8
    Brady CA, Hughes D, Drobatz KJ. Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure. J Vet Emerg Crit Care 2004; 14:177182.
  • 9
    Atkins CE, Gallo AM, Kurzman ID, et al. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases. J Am Vet Med Assoc 1992; 201:613618.
  • 10
    Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc 2002; 220:202207.
  • 11
    Tidholm A. Survival in dogs with dilated cardiomyopathy and congestive heart failure treated with digoxin, furosemide and propranolol: a retrospective study of 62 dogs. J Vet Cardiol 2006; 8:4147.
  • 12
    Borgarelli M, Savarino P, Crosara S, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008; 22:120128.
  • 13
    Häggström J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med 2008; 22:11241135.
  • 14
    O'Grady MR, Minors SL, O'Sullivan ML, et al. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med 2008; 22:897904.
  • 15
    International Small Animal Cardiac Health Council. Recommendations for diagnosis of heart disease and treatment of heart failure in small animals (Appendix A), In: FoxPR, SissonD, MoïseNS. eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia: WB Saunders; 1999, pp. 883901.
  • 16
    Laflamme DP. Development and validation of a body condition score system for dogs. Canine Pract 1997; 22:1015.
  • 17
    Laflamme D. Development and validation of a body condition score system for cats: a clinical tool. Feline Pract 1997; 25:1318.
  • 18
    Lombard CW. Normal values of the canine M-mode echocardiogram. Am J Vet Res 1984; 45:20152018.
  • 19
    Cobb M, Michell AR. Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J Small Anim Pract 1992; 33:526529.
  • 20
    Rush JE, Freeman LM, Brown DJ, et al. Clinical, echocardiographic, and neurohormonal effects of a sodium-restricted diet in dogs with heart failure. J Vet Intern Med 2000; 14:513520.
  • 21
    Galvao M, Kalman J, DeMarco T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the acute decompensated heart failure national registry (ADHERE). J Card Fail 2006; 12:100107.
  • 22
    Nieminem MS, Harjola VP, Hochadel M, et al. Gender related differences in patients presenting with acute heart failure. Results from euroheart failure survey II. Eur J Heart Failure 2008; 10:140148.
  • 23
    Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and in-hospital mortality for 108927 patients in the acute decompensated heart failure national registry. Am Heart J 2007; 153:7481.
  • 24
    Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165:5561.
  • 25
    Horwich TB, Fonorow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38:789795.
  • 26
    Lavie CJ, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003; 91:891895.
  • 27
    Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9:2935.
  • 28
    Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156:1322.
  • 29
    Slupe JL, Freeman LM, Rush JE. Association of body weight and body condition with survival in dogs with heart failure. J Vet Intern Med 2008; 22:561565.